Advertisement

Cytokines

  • Hajime Takizawa
Chapter
Part of the Progress in Inflammation Research book series (PIR)

Keywords

Allergy Clin Immunol Antimicrob Agent Airway Epithelial Cell Macrolide Antibiotic Human Bronchial Epithelial Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kudoh S, Uetake T, Hagiwara K, Hirayama M, Hus L-H, Kimura H, Sugiyama Y (1987) Clinical effect of low-dose, long-term erythromycin chemotherapy on diffuse panbronchiolitis. Jpn J Thorac Dis 25: 632–42Google Scholar
  2. 2.
    Kadota J, Sakito O, Kohno S, Sawa H, Mukae H, Oda H, Kawakami K, Fukushima K, Hiratani K, Hara K (1993) A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. Am Rev Respir Dis 147: 153–9PubMedGoogle Scholar
  3. 3.
    Spector S, Katz F, Farr R (1974) Troleandomycin: Effectiveness in steroid-dependent asthma and bronchitis. J Allergy Clin Immunol 54: 367–79CrossRefGoogle Scholar
  4. 4.
    Equi A, Balfour-Lynn IM, Bush A, Rosenthal M (2002) Long term azithromycin in children with cystic fibrosis: a randomized, placebo-controlled crossover trial. Lancet 360(9338): 978–84CrossRefPubMedGoogle Scholar
  5. 5.
    Saiman L, Marshall BC, Mayer-Hamblett N, Burns JL, Quittner AL, Cibene DA, Coquillette S, Fieberg AY, Accurso FJ, Campbell PW 3rd; Macrolide Study Group (2003) Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA 290(13): 1749–56CrossRefPubMedGoogle Scholar
  6. 6.
    Sakito O, Kadota J, Kohno S, Kabe K, Shirai R, Hara K (1994) Interleukin 1 beta, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: A potential mechanism of macrolide therapy. Respiration 63: 42–8Google Scholar
  7. 7.
    Takizawa H (1998) Airway epithelial cells as regulators of airway inflammation. Int J Mol Med 1: 367–78PubMedGoogle Scholar
  8. 8.
    Takizawa H, Ohtoshi T, Kawasaki S, Kohyama T, Sato M, Tanaka M, Kasama T, Kobayashi K, Nakajima K, Ito K (1997) Erythromycin modulates IL-8 expression in human bronchial epithelial cells: Studies with normal and inflamed airway epithelium. Am J Respir Crit Care Med 156: 266–71PubMedGoogle Scholar
  9. 9.
    Nakamura H, Yoshimura K, Jaffe HA, Crystal RG (1991) Interleukin-8 gene expression in human bronchial epithelial cells. J Biol Chem 266: 19611–17PubMedGoogle Scholar
  10. 10.
    Takizawa H, Desaki M, Ohtoshi T, Kikutani T, Okazaki H, Sato M, Akiyama N, Shoji S, Hiramatsu K, Ito K (1995) Erythromycin suppresses interleukin 6 expression by human bronchial epithelial cells. Biochem Biophys Res Commun 210: 781–6CrossRefPubMedGoogle Scholar
  11. 11.
    Kawasaki S, Takizawa H, Ohtoshi T, Takeuchi N, Kohyama T, Nakamura H, Kasama T, Kobayashi K, Nakahara K, Morita Y, Yamamoto K (1998) Roxithromycin inhibits cytokine production and neutrophil attachment with human bronchial epithelial cells in vitro. Antimicrob Agents Chemother 42: 1499–502PubMedGoogle Scholar
  12. 12.
    Takizawa H, Ohtoshi T, Takeuchi N, Ito K (1996) Effect of macrolide antibiotics on the expression and release of inflammatory cytokines in human bronchial epithelial cells. J Jpn Bronchoesophagol Soc 47: 185–8 ( in Japanese)Google Scholar
  13. 13.
    Khair OA, Devalia JL, Abdelaziz MM, Sapsford RJ, Davis RJ (1995) Effect of erythromycin on Hemophilus influenzae endotoxin-induced release of IL-6, IL-8 and sICAM-1 by cultured human bronchial epithelial cells. Eur Respir J 8: 1451–7Google Scholar
  14. 14.
    Iino Y, Toriyama M, Kudo K, Natori Y, You A (199). Erythromycin inhibition of lipopolysaccharide-stimulated tumour necrosis factor-alpha production by human monocytes in vitro. Ann Otol Rhinol Laryngol 101: 16–20Google Scholar
  15. 15.
    Fujii T, Kadota J, Morikawa T, Matsubara Y, Kawakami K, Iida K, Shirai R, Taniguchi H, Kaseda M, Kawamoto S, Kohno S (1996) Inhibitory effect of erythromycin on interleukin 8 production by 1alpha,25-dihydroxyvitamin D3-stimulated THP-1 cells. Antimicrob Agents Chemother 40: 1548–51PubMedGoogle Scholar
  16. 16.
    Khan AA, Slifer TR, Araujo FG, Remington JS (1999) Effect of clarithromycin and azithromycin on production of cytokines by human monocytes. Int J Antimicrob Agents 11(2): 121–32CrossRefPubMedGoogle Scholar
  17. 17.
    Sugiyama Y, Yanagisawa K, Tominaga S-I, Kitamura S (1999) Effects of long-term administration of erythromycin on cytokine production in rat alveolar macrophages. Eur Respir J 14: 1113–16CrossRefPubMedGoogle Scholar
  18. 18.
    Oishi K, Sonoda F, Kobayashi S, Iwagaki A, Nagatake T, Matsushima K, Matsumoto K (1994) Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases. Infect Immunity 62: 4145–52Google Scholar
  19. 19.
    Kamada AK, Hill MR, Ikle DN, Brenner AM, Szefler SJ (1993) Efficacy and safety of low-dose troleandomycin therapy in children with severe, steroid-requiring asthma. J Allergy Clin Immunol 91(4): 873–82CrossRefPubMedGoogle Scholar
  20. 20.
    Miyatake H, Taki F, Taniguchi H, Suzuki R, Takagi K, Satake T (1991) Erythromycin reduces the severity of bronchial hyperresponsiveness in asthma. Chest 99: 670–3PubMedGoogle Scholar
  21. 21.
    Konno S, Asano K, Kurokawa M, Ikeda K, Okamoto K, Adachi M (1994) Anti-asthmatic activity of a macrolide antibiotic, roxithromycin. Inter Archv Allergy Immunol 105: 308–16Google Scholar
  22. 22.
    Nakahara H, Higashida A, Nogami J, Iwanaga K, Ueshima H, Sawaguchi H, Haraguchi R, Muraki M, Kubo Y, Nakajima S (1997) Effect of roxithromycin on cytokine production by peripheral monocytes derived from patients with bronchial asthma. Jpn J Antibiotics 50(Suppl): 113–15 ( in Japanese )Google Scholar
  23. 23.
    Kohyama T, Takizawa H, Kawasaki S, Akiyama N, Sato M, Ito K (1999) Fourteenmember macrolides inhibit IL-8 release by human eosinophils from atopic donors. Antimicrob Agents Chemother 43: 907–11PubMedGoogle Scholar
  24. 24.
    Abe S, Nakamura H, Inoue S, Takeda H, Saito H, Kato S, Mukaida N, Matsushima K, Tomoike H (2000) Interleukin-8 gene repression by clarithromycin is mediated by the activator protein-1 binding site in human bronchial epithelial cells. Am J Respir Cell Mol Biol 22: 51–60PubMedGoogle Scholar
  25. 25.
    Desaki M, Takizawa H, Ohtoshi T, Kasama T, Kobayashi K, Sunazuka T, Omura S, Yamamoto K, Ito K (2000) Erythromycin suppresses nuclear factor-kappa B and activator protein-1 activation in human bronchial epithelial cells. Biochem Biophys Res Commun 267: 124–8CrossRefPubMedGoogle Scholar
  26. 26.
    Miyanohara T, Ushikai M, Matsune S, Ueno K, Katahira S, Kurono Y (2000) Effects of clarithromycin on cultured human nasal epithelial cells and fibroblasts. Laryngoscope 110(1): 126–31CrossRefPubMedGoogle Scholar
  27. 27.
    Kikuchi T, Hagiwara K, Honda Y, Gomi K, Kobayashi T, Takahashi H, Tokue Y, Watanabe A, Nukiwa T (2002) Clarithromycin suppresses lipopolysaccharide-induced interleukin-8 production by human monocytes through AP-1 and NF-kappa B transcription factors. J Antimicrob Chemother 49(5): 745–55CrossRefPubMedGoogle Scholar
  28. 28.
    Ichiyama T, Nishikawa M, Yoshitomi T, Hasegawa S, Matsubara T, Hayashi T, Furukawa S (2001) Clarithromycin inhibits NF-kappaB activation in human peripheral blood mononuclear cells and pulmonary epithelial cells. Antimicrob Agents Chemother 45(1): 44–7CrossRefPubMedGoogle Scholar
  29. 29.
    Desaki M, Okazaki H, Sunazuka T, Omura S, Yamamoto K, Takizawa H (2004) Molecular mechanisms of anti-inflammatory action of erythromycin in human bronchial epithelial cells: possible role in the signaling pathway that regulates nuclear factor-kappaB activation. Antimicrob Agents Chemother 48(5): 1581–5CrossRefPubMedGoogle Scholar
  30. 30.
    Hamada K, Kita E, Sawaki M, Mikasa K, Narita N (1995) Antitumor effect of erythromycin in mice. Chemotherapy 41(1): 59–69PubMedGoogle Scholar
  31. 31.
    Ortega E, Escobar MA, Gaforio JJ, Algarra I, Alvarez De Cienfuegos G (2004) Modification of phagocytosis and cytokine production in peritoneal and splenic murine cells by erythromycin A, azithromycin and josamycin. J Antimicrob Chemother 53(2): 367–70CrossRefPubMedGoogle Scholar
  32. 32.
    Dalhoff A, Shalit I (2003) Immunomodulatory effects of quinolones. Lancet Infect Dis 3(6): 359–71CrossRefPubMedGoogle Scholar
  33. 33.
    Khan AA, Slifer TR, Araujo FG, Suzuki Y, Remington JS (2000) Protection against lipopolysaccharide-induced death by fluoroquinolones. Antimicrob Agents Chemother 44(11): 3169–73CrossRefPubMedGoogle Scholar
  34. 34.
    Broide E, Douer D, Shaked N, Yellin A, Lieberman Y, Rosen N, Segev S, Rubinstein E (1992) Effect of short-term therapy with ciprofloxacin, ceftriaxone and placebo on human peripheral WBC and marrow-derived granulocyte-macrophage progenitor cells (CFU-GM) Eur J Haematol 48(5): 276–7PubMedGoogle Scholar
  35. 35.
    D’Agostino P, La Rosa M, Barbera C, Arcoleo F, Di Bella G, Milano S, Cillari E (1998) Doxycycline reduces mortality to lethal endotoxemia by reducing nitric oxide synthesis via an interleukin-10-independent mechanism. J Infect Dis 177(2): 489–92PubMedGoogle Scholar
  36. 36.
    Ramamurthy NS, Rifkin BR, Greenwald RA, Xu JW, Liu Y, Turner G, Golub LM, Vernillo AT (2002) Inhibition of matrix metalloproteinase-mediated periodontal bone loss in rats: a comparison of 6 chemically modified tetracyclines. J Periodontol 73(7): 726–34CrossRefPubMedGoogle Scholar
  37. 37.
    Kondo Y, Torii K, Omura S, Itoh Z (1988) Erythromycin and its derivatives with motilin-like biological activities inhibit the specific binding of 125I-motilin to duodenal muscle. Biochem Biophys Res Commun 150: 877–82CrossRefPubMedGoogle Scholar

Copyright information

© Birkhäuser Verlag Basel/Switzerland 2005

Authors and Affiliations

  • Hajime Takizawa
    • 1
  1. 1.Department of Respiratory MedicineUniversity of Tokyo, Graduate School of MedicineTokyoJapan

Personalised recommendations